NCT07758413

Brief Summary

The goal of this clinical trial is to learn if a Chinese medicine diabetes education programme is feasible and acceptable, and to explore its preliminary effects on self-management, for adults with type 2 diabetes in Hong Kong. The main questions it aims to answer are:

  1. 1.Is the Chinese medicine diabetes education programme feasible to deliver in a community setting (recruitment, retention and adherence)?
  2. 2.Is the programme acceptable to participants?
  3. 3.Does the programme show early signals of improving diabetes management self-efficacy and related outcomes?
  4. 4.Be randomly assigned to either a 4-week Chinese medicine diabetes education programme (four group sessions, total 4-6 hours) or usual care
  5. 5.Complete assessments at baseline, after the programme, and at 2-month follow-up.
  6. 6.Attend a focus group interview at the end of the study (selected participants)

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Jul 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Jul 2026Feb 2027

Study Start

First participant enrolled

July 30, 2026

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

August 6, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 11, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2027

Last Updated

August 11, 2026

Status Verified

August 1, 2026

Enrollment Period

4 months

First QC Date

August 6, 2026

Last Update Submit

August 6, 2026

Conditions

Keywords

Diabetes Mellituspatient educationself-managementmedicine, chinese traditional

Outcome Measures

Primary Outcomes (4)

  • Recruitment rate

    Proportion of eligible individuals who provide informed consent and are randomised into the study.

    From start of recruitment to end of recruitment period

  • Retention rate

    Proportion of randomised participants who complete the post-intervention assessment (T1) and the 2-month follow-up assessment (T2).

    From randomisation to 2-month follow-up

  • Adherence to the education programme

    Proportion of participants in the intervention group who attend at least 3 out of the 4 scheduled education sessions.

    During the 4-week intervention period

  • Acceptability of the programme

    Participant-reported acceptability and satisfaction with the Chinese medicine diabetes education programme, assessed by a structured questionnaire at the end of the programme. Additional qualitative feedback will be collected through focus group interviews at 2-month follow-up.

    At the end of the 4-week education programme

Secondary Outcomes (6)

  • Diabetes management self-efficacy

    Baseline, post-intervention (T1), and 2-month follow-up (T2)

  • Diabetes self-management behaviours

    Baseline, post-intervention (T1), and 2-month follow-up (T2)

  • Blood glucose level

    Baseline and 2-month follow-up (T2)

  • Blood lipid levels

    Baseline and 2-month follow-up (T2)

  • Body mass index (BMI)

    Baseline, post-intervention (T1), and 2-month follow-up (T2)

  • +1 more secondary outcomes

Study Arms (2)

Usual Care

NO INTERVENTION

Participants will continue their usual medical care and any existing diabetes education or support. No additional structured Chinese medicine diabetes education programme will be provided during the study. After the final follow-up, they will be offered the same education programme.

Chinese Medicine Diabetes Education Programme

EXPERIMENTAL

Participants will receive a 4-week Chinese medicine diabetes education programme consisting of four weekly group sessions (total 4-6 hours). Content includes Chinese medicine concepts of diabetes, body constitution, diet, emotional regulation, acupressure, skin and foot care, and physical activity.

Behavioral: Chinese Medicine Diabetes Education Programme

Interventions

A structured 4-week group education programme (four sessions, total contact time 4-6 hours) that integrates Chinese medicine concepts (body constitution, pattern differentiation, dietary therapy, emotional regulation, acupressure, and lifestyle advice) with modern diabetes self-management education.

Chinese Medicine Diabetes Education Programme

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years or above
  • Diagnosed with type 2 diabetes mellitus
  • Able to understand and communicate in Cantonese, and able to read Chinese
  • Willing and able to provide written informed consent
  • Able to attend the education sessions at the designated venues

You may not qualify if:

  • Severe cognitive impairment that would prevent meaningful participation in group education
  • Acute or unstable medical conditions, or serious chronic illnesses currently under active treatment (e.g., ongoing cancer treatment), that may preclude safe participation in group activities
  • Currently participating in another structured diabetes education research programme
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Yuen-Shan Ho, PhD

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 6, 2026

First Posted

August 11, 2026

Study Start

July 30, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

February 28, 2027

Last Updated

August 11, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share